CD274 and neoplasm: In such cases, upregulated PD-L1 expression is unrelated to active anti-tumor immunity, but rather, is a byproduct of oncogenic signaling; therefore, in these cases, upregulated PD-L1 is unlikely to indicate tumors that are susceptible to ICI-meditated anti-tumor immunity.